Deal round-up - April 20, 2018

IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


Deal round-up - April 20, 2018

Data Analyst Katrin Kostadinova highlights the most significant financial and corporate legal deals announced or closed in the last week

8272.png

Data Analyst Katrin Kostadinova highlights the most significant financial and corporate legal deals announced or closed in the last week

This week M&A has featured prominently. 

Americas

Beginning in the United States, Eldorado Resorts reached an agreement to acquire Tropicana Entertainment for $1.85 billion. The deal will see the acquirer take over the operation of seven casinos in six states.

Nasdaq-listed Hilton Worldwide Holdings has undertaken a secondary share offering, raising $4.8 billion.

The Bank of Montreal has issued $2.25 billion in senior notes - $1.5 billion 3.1% notes and $750 million floating rate notes.

Vermilion Energy is set to acquire Spartan Energy for C$1.4 billion in a stock deal.

Weir has reached an agreement to take over ESCO for $1.05 billion.

Europe, Middle East and Africa (EMEA)

In the Czech Republic, Advent International is set to acquire Zentiva for €1.91 billion from Sanofi. Zentiva is Sanofi’s European generics business. 

In a cross-border deal between Belgium and Italy, Athora Holding has reached an agreement to take over Generali's Belgium business for €540 million.

In France, Total is aiming to buy a majority stake in Direct Energie for €1.4 billion.

In Germany, Procter & Gamble is set to acquire Merck's consumer health business for $4.2 billion.

Richemont International Holding has undertaken a €4 billion notes issue in the United Kingdom. The issue consisted of €1.5 billion 1% notes due 2026, €1.25 billion 1.5% notes due 2030, and €1.25 billion 2% notes due 2038.

Another cross-border deal – this time between France, Ireland and the United Kingdom – has seen Servier reach an agreement to take over Shire’s oncology business for $2.4 billion.

Japan’s Takeda Pharmaceutical, meanwhile, has had a $63 billion bid for Shire rejected.

Singapore’s Temasek is set to acquire a 3.6% stake in Bayer for $3.7 billion as Bayer raises funds for its acquisition of Monsanto.

In Turkey, Yildiz Holding is restructuring $6.5 billion of its debt.

Gift this article